After years of losses exacerbated by a cyberattack in 2024, the Catholic health system has worked to realign its portfolio, prioritizing outpatient and ambulatory services and divesting inpatient facilities. Three internal principles drive the system's turnaround: CTC (Control the Controllables), BTB (Break the Bracket, using data-driven strategies to lift underperforming ministries) and EMS (Every Ministry should be Sustainable).
Cyborg Score Rationale
Ascension reported net income of positive $621 million through Q3 FY26 ending March 31, 2026. The organization significantly improved operating performance with a $262 million year-over-year improvement in operating losses and a 4.3% recurring operating EBIDA margin year to date. Strategic portfolio realignment and operational discipline have proven effective, though execution risks remain around the pending Amsurg acquisition.
Top Insights
For the nine months ending March 31, 2026, Ascension reported $621 million in net income, a 218% year-over-year improvement.
In June 2025, Ascension announced plans to acquire ambulatory surgery provider Amsurg; the deal, expected to close but yet to do so, will add more than 250 ambulatory surgery centers to Ascension's outpatient portfolio for almost $4 billion.
Through nine months of FY26, Ascension provided approximately $2.1 billion in community benefit, including $883 million in care for persons living in poverty and $1.3 billion of unreimbursed Medicare support.
In June 2025, Eduardo Conrado, current President, succeeded retiring CEO Joseph Impicciche effective January 1, 2026, after leading transformation in care delivery, digital infrastructure, and consumer engagement since 2018.
Named Competitors
Mayo Clinic — Integrated health system with hospitals and clinics across multiple states
Cleveland Clinic — Multi-state nonprofit health system
Atrium Health — Large integrated health system in Southeast and Midwest
Amsurg — Ambulatory surgery center operator; acquisition announced June 2025
Recent Developments
(May 2026) Q3 FY26: Ascension reported $621 million net income with $772 million recurring operating EBIDA and 4.3% margin, reflecting $262 million year-over-year improvement in operating performance
(February 2026) Q2 FY26: System posted $608 million net income for six months ended December 31, 2025, more than double prior-year period's $277 million
(January 2026) Leadership transition: Eduardo Conrado assumed role of President and CEO, succeeding Joseph Impicciche after more than 20 years of service
(June 2025) Amsurg acquisition: Ascension announced plan to acquire ambulatory surgery provider for approximately $4 billion to expand outpatient portfolio by over 250 ASCs
Open the full interactive Ascension Health report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.